Chargement en cours...
Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy
Antibody-drug conjugates (ADCs) are a class of highly potent biopharmaceutical drugs generated by conjugating cytotoxic drugs with specific monoclonal antibodies through appropriate linkers. Specific antibodies used to guide potent warheads to tumor tissues can effectively reduce undesired side effe...
Enregistré dans:
| Publié dans: | Molecules |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6152078/ https://ncbi.nlm.nih.gov/pubmed/28763044 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules22081281 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|